In a report released today, Tara Bancroft from TD Cowen maintained a Buy rating on Lantheus, with a price target of $95.00.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Tara Bancroft has given her Buy rating due to a combination of factors that suggest potential for Lantheus’s stock despite recent challenges. The company experienced a decline in Pylarify revenue, which was below expectations due to competitive pressures and pricing issues. However, Lantheus’s management has made strategic decisions to navigate these challenges, such as opting out of unfavorable contracts to maintain pricing integrity.
Furthermore, while the 2025 revenue guidance was slightly reduced, the overall market for PSMA PET is expected to grow, providing opportunities for Lantheus to capitalize on this expansion. The company’s decision to focus on sustainable pricing strategies and its ability to adapt to market dynamics underpin Bancroft’s confidence in Lantheus’s long-term potential, justifying the Buy rating.
In another report released on July 29, Leerink Partners also maintained a Buy rating on the stock with a $134.00 price target.